当前位置:首页 - 行情中心 - 仁和药业(000650) - 财务分析 - 现金流量表

仁和药业

(000650)

  

流通市值:80.15亿  总市值:84.28亿
流通股本:13.31亿   总股本:14.00亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,183,899,963.582,239,324,883.79853,461,972.414,682,139,870.22
  收到的税费返还9,566.879,566.879,566.872,025,309.36
  收到其他与经营活动有关的现金152,493,969.37113,614,112.3487,512,304213,237,385.42
  经营活动现金流入小计3,336,403,499.822,352,948,563940,983,843.284,897,402,565
  购买商品、接受劳务支付的现金1,641,990,931.591,085,631,515.73512,284,293.122,771,624,901.23
  支付给职工以及为职工支付的现金373,423,486.14274,687,525.18167,012,084.93543,830,545.49
  支付的各项税费236,942,118.38174,511,732.4768,244,310.79644,810,225.12
  支付其他与经营活动有关的现金243,562,700.58146,677,896.1675,157,819.88379,878,809.72
  经营活动现金流出小计2,495,919,236.691,681,508,669.54822,698,508.724,340,144,481.56
  经营活动产生的现金流量净额840,484,263.13671,439,893.46118,285,334.56557,258,083.44
二、投资活动产生的现金流量:
  收回投资收到的现金6,501,596,227.454,600,560,979.112,197,800,8849,568,514,696.44
  取得投资收益收到的现金59,326,090.0340,140,512.1425,860,447.9482,632,775.7
  处置固定资产、无形资产和其他长期资产收回的现金净额220,071.8532,234.7918,4808,949,585.71
  投资活动现金流入小计6,561,142,389.334,640,733,726.042,223,679,811.949,660,097,057.85
  购建固定资产、无形资产和其他长期资产支付的现金56,124,503.1242,411,635.4932,207,015.13285,717,962.97
  投资支付的现金8,357,743,246.236,451,769,798.854,120,629,086.139,836,817,599.98
  取得子公司及其他营业单位支付的现金95,461.923,169.71--
  投资活动现金流出小计8,413,963,211.256,494,204,604.054,152,836,101.2610,122,535,562.95
  投资活动产生的现金流量净额-1,852,820,821.92-1,853,470,878.01-1,929,156,289.32-462,438,505.1
三、筹资活动产生的现金流量:
  吸收投资收到的现金80,00080,000-2,640,000
  其中:子公司吸收少数股东投资收到的现金80,00080,000-2,640,000
  收到其他与筹资活动有关的现金-0-70,060,000
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计80,00080,000-72,700,000
  分配股利、利润或偿付利息支付的现金238,342,279.2211,818,640.332,160,774.19410,662,551.42
  其中:子公司支付给少数股东的股利、利润28,351,544.12,160,774.192,160,774.19130,731,378.07
  支付其他与筹资活动有关的现金-0045,821,237.3
  筹资活动现金流出小计238,342,279.2211,818,640.332,160,774.19456,483,788.72
  筹资活动产生的现金流量净额-238,262,279.2-211,738,640.33-2,160,774.19-383,783,788.72
五、现金及现金等价物净增加额-1,250,598,837.99-1,393,769,624.88-1,813,031,728.95-288,964,210.38
  加:期初现金及现金等价物余额2,325,564,672.742,325,564,672.742,325,564,672.742,614,528,883.12
  期末现金及现金等价物余额1,074,965,834.75931,795,047.86512,532,943.792,325,564,672.74
补充资料:
  净利润-355,240,856.89-566,585,713.01
  资产减值准备--99,651.05-113,319,610.32
  固定资产和投资性房地产折旧-49,866,986.19-92,577,772.52
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-49,866,986.19-92,577,772.52
  无形资产摊销-7,251,544.98-24,028,495.66
  长期待摊费用摊销-1,811,477.82-2,840,724.84
  处置固定资产、无形资产和其他长期资产的损失--2,000,511.4--1,365,132.54
  固定资产报废损失-149,572.46-63,736.29
  公允价值变动损失--39,303.94--16,033,837.69
  财务费用-43,293.13-166,965.55
  投资损失--26,729,093.05--72,701,938.99
  递延所得税-2,389,711.5--6,164,484.39
  其中:递延所得税资产减少-2,419,071.41--4,394,232.98
    递延所得税负债增加--29,359.91--1,770,251.41
  存货的减少-121,785,151.43-7,713,384.28
  经营性应收项目的减少--19,579,650.04-149,680,170.77
  经营性应付项目的增加-164,308,462.55--353,640,485.9
  其他-8,134,270.8-15,529,062.5
  现金的期末余额-931,795,047.86-2,325,564,672.74
  减:现金的期初余额-2,325,564,672.74-2,614,528,883.12
  现金及现金等价物的净增加额--1,393,769,624.88--288,964,210.38
公告日期2025-10-312025-08-262025-04-292025-04-26
审计意见(境内)标准无保留意见
TOP↑